Lacto-N-neodifucohexaose II
Lacto-N-neodifucohexaose II (Compd 9) is a derivative of key human milk tetrasaccharide[1]. Lacto-N-neodifucohexaose II is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Product Specifications
CAS Number
2583908-45-4
Product Name Alternative
LNnDFH II
UNSPSC
12352005
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/lacto-n-neodifucohexaose-ii.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]([C@H]([C@H]([C@@H]1O)O)O)O[C@@H]1O[C@@H]([C@@H](O[C@@H]([C@H]2NC(C)=O)O[C@H]3[C@@H]([C@H](O[C@H]([C@H]3O)CO)O[C@@H]4[C@H]([C@@H]([C@H](O[C@H]4CO)OCCCCCCN=[N+]=[N-])O)O[C@@H]5[C@@H]([C@H]([C@H]([C@H](O5)C)O)O)O)O)CO)[C@H]2O[C@@H]6[C@@H]([C@H]([C@H]([C@H](O6)C)O)O)O
Molecular Formula
C44H76N4O29
Molecular Weight
1125.08
References & Citations
[1]Yingying Zhu, et al. Physiological effects, biosynthesis, and derivatization of key human milk tetrasaccharides, lacto- N-tetraose, and lacto- N-neotetraose. Crit Rev Biotechnol. 2022 Jun;42 (4) :578-596.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940031-100 1x 100 µL
Mucin 5AC (MUC5AC) (45M1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC140017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740723-100 1x 100 µL
P53 (BP53-12 + DO-7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details